USP <61> and <62> Microbiology Testing: Why Botanical Ingredients Fail More Often Than You'd Expect

Walk through any dietary supplement manufacturing floor and ask the quality manager which raw material keeps them up at night. Odds are they won’t say magnesium stearate or ascorbic acid. They’ll point to the botanical bin.

Herbal ingredients are agricultural products. They’re grown in soil, harvested in the field, and dried in warm, humid conditions across India, Southeast Asia, and East Africa. They carry an inherent microbial load that synthetic raw materials simply don’t, and that load doesn’t always behave the way brands expect once it moves through the production process. USP <61> and <62> are the tests that quantify what’s actually present — and the results surprise supplement companies more often than they should. Any qualified analytical testing laboratory running GMP-compliant raw material release will tell you the same thing: botanicals are consistently the highest-risk category on the incoming materials list.

What USP <61> and <62> Are Actually Testing

These two chapters from the United States Pharmacopeia do different jobs, and it’s worth being precise about the distinction.

USP <61> covers microbial enumeration: Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC). These are quantitative tests — they tell you how many colony-forming units per gram (CFU/g) of viable bacteria, yeast, and mold are present in a sample. Methods typically involve membrane filtration or serial dilution on Tryptic Soy Agar for bacteria and Sabouraud Dextrose Agar for yeast and mold, incubated at defined temperatures with read-out at 48 to 72 hours depending on organism type.

USP <62> is qualitative — a pass/fail screen for specific objectionable microorganisms: Salmonella spp., Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and in certain product categories, Candida albicans and Clostridia. Proper <62> testing involves enrichment broth steps, selective plating, and biochemical or immunoassay confirmation. Done correctly, it takes 5 to 7 business days — not 48 hours. Any analytical testing laboratory offering same-day or next-day <62> results should be asked directly how they’re validating their Salmonella confirmation step. Shortcuts exist in the industry, and they produce false negatives that tend to surface at exactly the wrong moment.

Together, these two chapters give a complete microbial picture: overall bioburden counts plus pathogen presence or absence. For any raw botanical ingredient, running both is baseline practice, not optional.

The Acceptance Criteria Gap Nobody Talks About

Here’s the issue that trips up Midwest supplement brands more than any other single point in microbiology: acceptance limits differ dramatically depending on which stage of production you’re testing.

USP <1111> — the chapter that defines microbiological acceptance criteria for pharmaceutical preparations — sets Category 5A limits for dried herbal preparations intended for oral use:

• TAMC: ≤ 10^7 CFU/g
• TYMC: ≤ 10^5 CFU/g
• E. coli: ≤ 10^2 CFU/g

These limits acknowledge that raw botanical material is an agricultural commodity. A dried ashwagandha root powder with a TAMC of 500,000 CFU/g passes Category 5A without issue. That number looks alarming on paper — and it would be, in a finished capsule — but it’s within specification for a raw material at this stage of the supply chain.

The problem is what happens downstream. Finished oral dietary supplements — non-aqueous solid dosage forms like capsules and tablets — fall under Category 2:

• TAMC: ≤ 10^3 CFU/g
• TYMC: ≤ 10^2 CFU/g

That’s a 10,000-fold reduction in allowable bacterial count between a compliant raw material and a compliant finished product. If your botanical blend enters the encapsulation line at 10^6 CFU/g — passing raw material spec — and your manufacturing process doesn’t include any validated microbial reduction step, your finished capsule fill may test well above Category 2 TAMC limits.

We see this with Chicago-area brands regularly. The raw material CoA says pass. The finished product micro test fails. The root cause isn’t contamination during manufacturing — it’s arithmetic. The bioburden present in the incoming ingredient was never accounted for in the product’s microbial risk assessment, if one was even written.

Why Botanicals Fail at Higher Rates Than Other Supplement Ingredients

The failure pattern isn’t random. Certain botanical classes and sourcing regions carry predictably elevated risk, and experienced analysts at any accredited analytical testing laboratory will recognize these patterns immediately.

Root and rhizome herbs — turmeric, ashwagandha, ginger, valerian, licorice root — have the highest soil exposure at harvest. Soil is a reservoir for Bacillus species, Clostridium spores, and mold, including aflatoxigenic strains of Aspergillus. Microbial load in these materials can run high enough that steam sterilization or ethylene oxide treatment is essentially required to bring finished-product specs within range. Both of those treatments require validation studies to confirm they don’t degrade your active marker compounds — a step many contract manufacturers skip.

Herbs grown under flood irrigation, particularly in India and Pakistan, carry elevated E. coli and fecal coliform risk. Irrigation water drawn from sources near livestock agriculture or inadequate sanitation infrastructure introduces fecal coliforms directly into contact with root systems. Under Category 5A, up to 100 CFU/g of E. coli is technically permissible in a raw herb powder. In a finished oral product, the tolerance is essentially zero.

High-moisture botanicals dried in humid ambient conditions without climate-controlled storage are prone to TYMC exceedances that can reach 10^6 CFU/g — above even the lenient Category 5A yeast and mold limit of 10^5 CFU/g. This shows up most frequently in ginger, morinda root, and tropical adaptogenic herbs dried in open-air conditions in South Asia before being containerized for trans-Pacific shipping. By the time the material reaches a Midwest warehouse, the mold count may have been climbing for three weeks.

Salmonella operates under different rules entirely. The organism isn’t common in botanicals, but when it’s present, the acceptance category framework doesn’t apply — Salmonella must be absent in a 10g test sample for any oral product under USP <62>, whether raw material or finished dosage form. FDA Warning Letters and Class I recall actions involving botanical supplements have repeatedly cited Salmonella traced to ingredients sourced from facilities with inadequate pest control or cross-contamination with animal-derived inputs processed on shared equipment.

Building a Complete Microbiological Testing Program for Botanical Inputs

When brands ask us what a complete micro test package should include for botanical raw materials, here’s what we recommend — and what a properly accredited analytical testing laboratory should be able to provide with method traceability and documented QC:

1. TAMC and TYMC per USP <61> — non-negotiable for every lot of every botanical ingredient, regardless of supplier history
2. Full USP <62> pathogen panel — Salmonella, E. coli, S. aureus, P. aeruginosa as the baseline; add Candida albicans for products marketed to immunocompromised populations
3. Bile-tolerant gram-negative bacteria (BTGNB) count per USP <2021> or equivalent — a useful early hygiene signal before a full <62> panel completes, particularly for root-sourced materials
4. Total Enterobacteriaceae count where ingredients originate from high-risk irrigation regions — provides a broader contamination picture than E. coli alone
5. Retain and seal reserve samples for every tested lot, documented with micro results and storage conditions — essential for traceback if a finished-product failure surfaces weeks or months later in the production cycle

Under 21 CFR Part 111.75, dietary supplement manufacturers must establish written specifications for each dietary ingredient and verify through testing or examination that those specifications are met before use in production. Accepting a supplier CoA without incoming verification testing is only compliant if you’ve validated the supplier’s testing procedures and have written documentation of that validation on file. Most small and mid-sized supplement brands in the Midwest have never done that supplier validation work — which means, technically, every incoming botanical lot accepted on supplier CoA alone represents a documentation gap under cGMP.

What to Check on a Supplier’s Micro CoA Before You Trust It

Four questions worth asking before you accept any botanical ingredient based on a supplier’s Certificate of Analysis:

Does the CoA cite specific method references? “TAMC per USP <61>” is acceptable. “APC” with no method citation is not — it could mean anything from a validated pharmacopeial method to a dipstick test. Method traceability is the minimum bar.

Are the units correct? TAMC for a powder should be reported in CFU/g, not CFU/mL. A mislabeled unit isn’t just sloppy — it can indicate the sample was tested as a liquid suspension without dry-weight correction, which produces artificially low counts.

What is the detection limit? A result of “ND” (not detected) is meaningless without a stated detection limit. If the method can’t detect below 100 CFU/g and the product specification calls for ≤ 10 CFU/g, “ND” is not a passing result. It’s a non-result.

Is the testing laboratory ISO 17025 accredited? ISO 17025 accreditation requires method validation, interlaboratory proficiency participation, and documented quality management systems. It’s the standard that separates analytical testing laboratories producing defensible data from those operating without external verification. Check whether microbiology is within the lab’s accredited scope specifically — accreditation in chemistry alone doesn’t cover micro methods.

---

Your botanical ingredients carry more microbial risk than anything else in your formulation. A validated test method, the right acceptance criteria framework, and a CoA from a laboratory accountable enough to defend its numbers — that’s the combination that protects your finished product and your brand. Build that program before you start blending, not after your first recall notice.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days Contact us

Related from our network

• ISO 17025 Accreditation for Dietary Supplement Testing: What It Means for Your CoA — Qalitex Laboratories explains what accreditation scope covers and why it matters when evaluating analytical laboratory results for supplement compliance.
• Heavy Metals Testing Under USP <232> and <233>: ICP-MS Methods for Herbal Raw Materials — How Qalitex’s ICP-MS capabilities address elemental impurity limits across botanical ingredient categories alongside microbiology panels.